Quanterix Corp
Company Profile
Business description
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
Contact
900 Middlesex Turnpike
BillericaMA01821
USAT: +1 617 301-9400
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
136
Stocks News & Analysis
stocks
Going into earnings, is Microsoft stock a buy, a sell, or fairly valued?
stocks
Tesla earnings: Shares fall as market focuses on uncertainty in near term
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,317.20 | 26.50 | -0.28% |
| CAC 40 | 8,202.78 | 23.00 | -0.28% |
| DAX 40 | 24,240.28 | 32.49 | 0.13% |
| Dow JONES (US) | 47,152.75 | 418.14 | 0.89% |
| FTSE 100 | 9,610.19 | 31.62 | 0.33% |
| HKSE | 26,160.15 | 192.17 | 0.74% |
| NASDAQ | 23,200.24 | 258.45 | 1.13% |
| Nikkei 225 | 49,299.65 | 658.04 | 1.35% |
| NZX 50 Index | 13,391.59 | 14.49 | 0.11% |
| S&P 500 | 6,795.03 | 56.59 | 0.84% |
| S&P/ASX 200 | 9,019.00 | 25.20 | -0.28% |
| SSE Composite Index | 3,950.31 | 27.90 | 0.71% |